Patients who received a recalled Stryker Rejuvenate or Stryker AGB II metal-on-metal hip replacement will likely have to be monitored for life, according to orthopedic surgeon Doctor Win Moore III. Patients will need to be monitored for high levels of cobalt and chromium in the bloodstream — an indicator of metal poisoning, a serious Stryker hip implant side effect.
In some patients, metallosis, or toxic levels of metal in the bloodstream, can occur even if a patient shows no other symptoms of a faulty hip implant. According to Dr. Moore, nearly 1 in 4 patients who he fitted with a Stryker hip replacement required revision surgery to remove the device. Moore described the ordeal as very stressful for his team and his patients.
Stryker released its ABG II and Rejuvenate devices in 2007 and issued a hip implant recall in 2012 after several studies found that the device had an increased likelihood of failing compared to other replacements. Dr. Moore “strongly recommend(s) anyone who has a defective device contact an attorney.”
Thousands of patients have filed a Stryker lawsuit alleging that the company released a defective device which caused serious injuries, including tissue damage, pain and limited mobility. In 2014, a $1.4 billion Stryker settlement resolved many of those lawsuits, though patients who don’t take part in the settlement are still eligible to file a lawsuit against the company.